30,000 people to enter final testing phase of COVID-19 vaccine


Share post:

An experimental vaccine developed by the National Institute of Health and Moderna Inc will start the final testing phase in the U.S. beginning with 30,000 people on July 27th.

The testing will be a key phase in the road to a vaccine against COVID-19.

“No matter how you slice this, this is good news,” Dr. Anthony Fauci, the U.S. government’s top infectious disease expert, told The Associated Press.

Fauci’s colleagues at the Institute are the developers behind the would be vaccine. The phase is being entered following a testing of 45 volunteers, who submitted to testing in March.  The goal of the vaccine is to offer an immune boost against the pandemic.

There are no guarantees to the virus, but it would require two doses, set two months apart to administer.

Side effects were reported with the drug with over half of participants reporting reactions uncommon to other vaccines, including fatigue, headache, chills, fever and pain at the injection site.


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related articles

Wheaton, IL: Paris Saint-Germain Academy Hosts Summer Soccer Camp

Get ready, Wheaton! The Paris Saint-Germain Academy is bringing its 2024 Summer Soccer Camp to our town from...

Elmhurst Bank Robbery: Police Ask for Public’s Help in Suspect ID

Elmhurst, IL - Police are seeking public assistance in identifying a suspect involved in a bank robbery. According to...

Westbound I-70 Closed Due to Semi Truck Collision Near Greenfield

Greenfield, IN - Westbound I-70 at the 131 mile marker is closed following a crash Friday afternoon involving...

Arkansas Amber Alert: 3-Year-Old Kaiden Brown Missing from Texarkana

Texarkana, AR – An Amber Alert has been issued for Kaiden Brown, a 3-year-old boy missing from Texarkana,...